Kidney disease progression and all-cause mortality across estimated glomerular filtration rate and albuminuria categories among patients with vs. without type 2 diabetes
Gregory A. Nichols(Kaiser Permanente Center for Health Research), Sibylle J. Hauske(Heidelberg University), A. Gabriela Rosales(Kaiser Permanente Center for Health Research), Teresa M. Kimes(Kaiser Permanente Center for Health Research), Kimberly G. Brodovicz(United States Military Academy), Anouk Déruaz‐Luyet(Boehringer Ingelheim (Germany))
Cited by 48
Related Papers
Impact of diabetes on the effects of sodium glucose co-transporter-2 inhibitors on kidney outcomes: collaborative meta-analysis of large placebo-controlled trials
|The Lancet|2022|1k
Hepatitis B Vaccination and the Risk of Multiple Sclerosis
|New England Journal of Medicine|2001|432
The Burden of Treatment Failure in Type 2 Diabetes
|Diabetes Care|2004|426